Summary Information for: Access® Hybritech® PSA reagents on the Access® Immunoassay Systems

Published in July 24th, 2008

Posted by Food and Drug Adminstration (FDA): CDRHNew in Medical Devices and Radiological Health

Comments Off

PDF format only. Topics: Reagents

Consumer Information on: EVOLENCE® Collagen Filler - P070013

Published in July 24th, 2008

Posted by CDRH Consumer News in Medical Devices and Radiological Health

Comments Off

Evolence® Collagen Filler is a sterile, injectable, biodegradable, yellowish, opaque gel that is injected into the inner layers of facial skin (mid to deep dermis) in order to correct moderate to deep facial wrinkles and folds such as those around the…

U.S. Urges Genetic Test Before Using Glaxo AIDS Drug

Published in July 24th, 2008

Comments Off

HIV patients should be given a genetic test before treatment with GlaxoSmithKline Plc’s drug, Ziagen (abacavir), to see if they face a higher risk of a potentially fatal reaction, U.S. regulators said on Thursday.
Reuters Health Information

Mumps Antibody Levels Decrease Over Time

Published in July 24th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

Lower levels of mumps neutralizing antibody are seen in individuals who received the second dose of the MMR vaccine 15 or more years prior compared with those who received this dose in the last 1 to 5 years, new research shows.
Reuters Health Information

More Than 1,000 Died in U.S. From Illegal Fentanyl

Published in July 24th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

At least 1,013 people died of overdoses in several U.S. cities from 2005 to 2007 after illegally injecting non-pharmaceutical fentanyl, U.S. officials said on Thursday.
Reuters Health Information

Emphysematous Pyelonephritis Manageable Without Surgery

Published in July 24th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

In the majority of patients, conservative management yields a good outcome in dealing with emphysematous pyelonephritis, according to Indian researchers.
Reuters Health Information

Effective HIV Suppression Does Not Eliminate Transmission Risk

Published in July 24th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

Antiretroviral therapy that reduces plasma viral load to undetectable levels is no guarantee that the HIV-infected individual is no longer infectious, epidemiologists in Australia report in the July 26 issue of The Lancet. They present data suggesting that failure to use condoms following effective treatment could substantially increase sexual transmission of HIV.
Reuters Health Information

Earlier Vaccination Curtails Measles Outbreaks in Low-Income Countries

Published in July 24th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

Giving infants their first measles inoculation at 4.5 months of age instead of waiting until 9 months provides better protection and reduces mortality during measles outbreaks in developing countries, according to data compiled during such an outbreak in Guinea-Bissau.
Reuters Health Information

Cinacalcet Inhibits Parathyroid Hormone Secretion in Hemodialysis Patients

Published in July 24th, 2008

Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News

Comments Off

Spanish researchers report that in hemodialysis patients with secondary hyperparathyroidism, treatment with the calcimimetic cinacalcet changes the dynamics of parathyroid hormone (PTH) secretion by increasing sensitivity of the parathyroid calcium-sensing receptor to calcium.
Reuters Health Information

Barr confirms Fentora tablet patent challenge

Published in July 24th, 2008

Posted by Pharmaceutical News Feed in Drugs and Food Information, Pharmaceutical Industry News

Comments Off

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Cephalon, Inc. in connection with its Fentora(R) Tablets (fentanyl citrate buccal tablets), equivalent to fentanyl base 100 mcg, 400 mcg, 600 mcg and 800 mcg.

« Older Entries